SEC filing record
Primary Source · SEC.gov

SS Innovations International, Inc.

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2026-03-19Last filing 2026-03-19

Raised

$19M

Investors

25

Min Invest

$75,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

SS Innovations International, Inc. is a Florida corporation that filed a Form D with the SEC on March 19, 2026 in the Biotechnology industry group. The offering claims Rule 506(b) and covers equity. SS Innovations International, Inc. reported $18,621,498 sold from 25 investors of a $18,621,498 total offering as of the Form D filed March 19, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $75,000. The Form D names Roth Capital Partners, LLC (CRD 000015407), associated with None as the recipient of sales compensation soliciting in FL. Sales commissions are reported as $175,000 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 405, 3rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, 122016.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001676163
Entity NameSS Innovations International, Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationFlorida
Issuer Address405, 3rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, 122016
Phone(954) 478-1410
Former NamesSS Innovations International, Inc. (until November 16, 2026); AVRA Medical Robotics, Inc. (until April 14, 2023)
Industry / Fund TypeBiotechnology
Securities TypeEquity
First Sale DateMarch 6, 2026
Filing DateMarch 19, 2026
Accession Number0001213900-26-031834
Total Offering Amount$18,621,498
Total Amount Sold$18,621,498
Amount Remaining$0
Total Investors25
Non-Accredited InvestorsNone
Minimum Investment$75,000
Offering DurationOne year or less
Sales Commissions$175,000 (to Roth Capital Partners, LLC)
Finders' Fees$0
Revenue Range$25,000,001 - $100,000,000
State (Issuer Address)K7
Amendment Count4 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

2

latest Mar 19, 2026

Critical / warning

0 / 0

0 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

4

lapsed, closed

Latest event New filer · Mar 19, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 2 filing events with values and deltas, latest 2026-03-19, and alerts on the next one
  • 4 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2026-03-19: 3 related persons added and 1 removed against the filing of 2024-02-27; 8 now listed. The names are in the Terminal feed.

Sudhir Prem Srivastava

Executive Officer, Director · Gurugram, Haryana, K7

Chairman and Chief Executive Officer

Milan Prem Rao

Executive Officer · Gurugram, Haryana, K7

Global Chief Operating Officer and Chief Financial Officer

Vishwajyoti P. Srivastava

Executive Officer, Director · Gurugram, Haryana, K7

Chief Executive Officer - Asia Pacific and Director

Barry F. Cohen

Executive Officer, Director · Gurugram, Haryana, K7

Chief Operating Officer - Americas and Director

Mylswamy F. Annadurai

Director · Gurugram, Haryana, K7

Director

S.P. F. Somashekhar

Director · Gurugram, Haryana, K7

Director

Frederic H. Moll

Director · Gurugram, Haryana, K7

Director

Tim H. Adams

Director · Gurugram, Haryana, K7

Director

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Roth Capital Partners, LLCCRD 000015407 on BrokerCheck

Associated broker-dealer: None · Newport Beach, CA · Soliciting in FL

Questions About SS Innovations International, Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is SS Innovations International, Inc.?

SS Innovations International, Inc. is a Florida corporation that filed a Form D with the SEC on March 19, 2026 in the Biotechnology industry group. The filing claims Rule 506(b) for an offering of equity.

Is SS Innovations International, Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. SS Innovations International, Inc. filed a Form D with the SEC on March 19, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $18,621,498 sold to 25 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is SS Innovations International, Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that SS Innovations International, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has SS Innovations International, Inc. raised?

SS Innovations International, Inc. reported $18,621,498 sold from 25 investors of a $18,621,498 total offering as of the Form D filed March 19, 2026.

Who can invest in SS Innovations International, Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $75,000.

What is the minimum investment in SS Innovations International, Inc.?

The Form D lists $75,000 as the minimum investment accepted from any outside investor as of March 19, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling SS Innovations International, Inc. and how are they paid?

The Form D names Roth Capital Partners, LLC (CRD 000015407), associated with None as the recipient of sales compensation soliciting in FL. Sales commissions are reported as $175,000 and finders' fees as $0. Form D allows these to be estimates.

Who is behind SS Innovations International, Inc.?

The Form D lists 8 related persons: Sudhir Prem Srivastava, executive officer, director (Chairman and Chief Executive Officer); Milan Prem Rao, executive officer (Global Chief Operating Officer and Chief Financial Officer); Vishwajyoti P. Srivastava, executive officer, director (Chief Executive Officer - Asia Pacific and Director); Barry F. Cohen, executive officer, director (Chief Operating Officer - Americas and Director); Mylswamy F. Annadurai, director (Director); S.P. F. Somashekhar, director (Director); Frederic H. Moll, director (Director); Tim H. Adams, director (Director). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is SS Innovations International, Inc. located?

The issuer's address on its SEC filings is 405, 3rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, 122016. Its phone number of record is (954) 478-1410. It is organized under the laws of Florida.

How long is the SS Innovations International, Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is SS Innovations International, Inc.'s revenue?

The Form D reports a revenue range of $25,000,001 - $100,000,000.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.